FFO
ABBV icon

Fiduciary Family Office’s AbbVie ABBV Stock Holding History

Fiduciary Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Sell
13,857
-283
-2% -$60.9K 0.87% 18
2026
Q1 		$3.08M Buy
14,140
+4,249
+43% +$943K 0.88% 18
2025
Q4 		$2.26M Buy
9,891
+111
+1% +$25.3K 0.65% 28
2025
Q3 		$2.26M Buy
9,780
+908
+10% +$185K 0.64% 26
2025
Q2 		$1.65M Sell
8,872
-678
-7% -$126K 0.54% 35
2025
Q1 		$2M Buy
+9,550
New +$1.86M 0.67% 26
2024
Q4 		– Sell
-6,926
Closed -$1.37M – 76
2024
Q3 		$1.37M Sell
6,926
-216
-3% -$40.3K 0.45% 45
2024
Q2 		$1.22M Sell
7,142
-2,613
-27% -$433K 0.48% 51
2024
Q1 		$1.78M Buy
9,755
+301
+3% +$51.9K 0.7% 33
2023
Q4 		$1.47M Buy
+9,454
New +$1.38M 0.64% 28

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fiduciary Family Office's ABBV Position: Q2 2026 in Review

Fiduciary Family Office reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $60.9K and leaving 13,857 shares worth $3.49M. The position accounts for 0.87% of the portfolio, ranked #18.

Fiduciary Family Office first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fiduciary Family Office held 13,857 shares of AbbVie worth $3.49M as of Q2 2026.
  • Fiduciary Family Office sold 283 AbbVie shares in Q2 2026, an estimated $60.9K.
  • AbbVie made up 0.87% of Fiduciary Family Office's portfolio in Q2 2026, its #18 holding.
  • Fiduciary Family Office first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.